Sapphiros And Cencora, Formerly AmerisourceBergen Corporation, Enter Into Distribution Agreement
Portfolio Pulse from Benzinga Newsdesk
Sapphiros has entered into a distribution agreement with Cencora, Inc. (formerly AmerisourceBergen Corporation) to distribute Sapphiros's GoToKnow™ COVID-19 Antigen Rapid Tests to U.S. pharmacies. The partnership will also give Cencora access to future Sapphiros technologies, including a new diagnostics platform, additional rapid tests, and a novel blood collection patch expected in early 2024.
November 22, 2023 | 2:02 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Cencora, Inc. (formerly AmerisourceBergen Corporation) has partnered with Sapphiros to distribute COVID-19 rapid tests, with potential future expansion to other diagnostic technologies.
The distribution agreement with Sapphiros could potentially increase Cencora's product offerings and market presence in the diagnostic sector, which is likely to have a positive impact on the company's stock in the short term. The partnership indicates growth in Cencora's distribution capabilities and could lead to increased revenue streams from the sale of COVID-19 tests and future diagnostic products.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 80